spacer
spacer

PDBsum entry 6tca

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Signaling protein PDB id
6tca

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
345 a.a.
346 a.a.
326 a.a.
Ligands
39G ×4
PDB id:
6tca
Name: Signaling protein
Title: Phosphorylated p38 and mapkapk2 complex with inhibitor
Structure: Map kinase-activated protein kinase 2. Chain: a, c, e, g. Synonym: mk2. Engineered: yes. Mitogen-activated protein kinase 14. Chain: b, d, f, h. Synonym: mapk 14,cytokine suppressive anti-inflammatory drug-binding protein,csbp,map kinase mxi2,max-interacting protein 2,mitogen- activated protein kinase p38 alpha,map kinase p38 alpha,stress-
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: mapkapk2. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: mapk14, csbp, csbp1, csbp2, cspb1, mxi2, sapk2a. Expression_system_taxid: 562
Resolution:
3.70Å     R-factor:   0.254     R-free:   0.297
Authors: P.Sok,A.Remenyi
Key ref: P.Sok et al. (2020). MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases. Structure, 28, 1101. PubMed id: 32649858 DOI: 10.1016/j.str.2020.06.007
Date:
05-Nov-19     Release date:   22-Jul-20    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P49137  (MAPK2_HUMAN) -  MAP kinase-activated protein kinase 2 from Homo sapiens
Seq:
Struc:
400 a.a.
345 a.a.
Protein chains
Pfam   ArchSchema ?
Q16539  (MK14_HUMAN) -  Mitogen-activated protein kinase 14 from Homo sapiens
Seq:
Struc:
360 a.a.
346 a.a.*
Protein chains
Pfam   ArchSchema ?
P49137  (MAPK2_HUMAN) -  MAP kinase-activated protein kinase 2 from Homo sapiens
Seq:
Struc:
400 a.a.
326 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: Chains A, C, E, G: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
   Enzyme class 2: Chains B, D, F, H: E.C.2.7.11.24  - mitogen-activated protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.str.2020.06.007 Structure 28:1101 (2020)
PubMed id: 32649858  
 
 
MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases.
P.Sok, G.Gógl, G.S.Kumar, A.Alexa, N.Singh, K.Kirsch, A.Sebő, L.Drahos, Z.Gáspári, W.Peti, A.Reményi.
 
  ABSTRACT  
 
Mitogen-activated protein kinases (MAPKs) control essential eukaryotic signaling pathways. While much has been learned about MAPK activation, much less is known about substrate recruitment and specificity. MAPK substrates may be other kinases that are crucial to promote a further diversification of the signaling outcomes. Here, we used a variety of molecular and cellular tools to investigate the recruitment of two substrate kinases, RSK1 and MK2, to three MAPKs (ERK2, p38α, and ERK5). Unexpectedly, we identified that kinase heterodimers form structurally and functionally distinct complexes depending on the activation state of the MAPK. These may be incompatible with downstream signaling, but naturally they may also form structures that are compatible with the phosphorylation of the downstream kinase at the activation loop, or alternatively at other allosteric sites. Furthermore, we show that small-molecule inhibitors may affect the quaternary arrangement of kinase heterodimers and thus influence downstream signaling in a specific manner.
 

 

spacer

spacer